ClinConnect ClinConnect Logo
Search / Trial NCT06887244

Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial Toxicity

Launched by NATIONAL CANCER INSTITUTE, NAPLES · Mar 19, 2025

Trial Information

Current as of April 23, 2025

Recruiting

Keywords

Colonoscopy Tele Consultation Procedure Colon Cancer Financial Toxicity Anxiety Procedure Related

ClinConnect Summary

This clinical trial is studying how effective tele-consultations with nurses are for patients getting elective colonoscopies. A colonoscopy is a procedure used to check the health of your colon and can help in preventing colon cancer. The trial will look at how these tele-consultations may improve the quality of the colonoscopy, reduce anxiety related to the procedure, and lessen financial burdens for patients.

To participate, you need to be between 65 and 80 years old and eligible for outpatient colonoscopy for reasons like screening or follow-up after previous treatments. However, if you are under 18 or over 80, pregnant, have certain medical conditions, or cannot provide informed consent, you won’t be eligible. If you join the study, you will receive a tele-consultation before your procedure, and the researchers will assess how this affects your experience during the colonoscopy. This trial is currently recruiting participants, and your involvement could help improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects eligible for outpatient pancolonoscopy:
  • for diagnostic purposes;
  • for screening purposes;
  • for post-polypectomy follow-up;
  • of both genders;
  • of all ethnicities;
  • Exclusion Criteria:
  • Patients under 18 years of age or over 80 years of age;
  • Patients on waiting lists with SHORT priority: the procedure to be provided within a short time (no more than 10 days);
  • Patients included in GOM pathways who undergo colonoscopy within 10 days;
  • Pregnancy;
  • Presence of known contraindications to bowel preparation;
  • Presence of known contraindications to performing pancolonoscopy;
  • Patients who have undergone colonic resection and/or have a colostomy/ileostomy;
  • Patients with cognitive impairments;
  • Patients declared legally incompetent or unable to understand and make decisions;
  • Patients unable to provide informed consent.

Trial Officials

Francesco De Falco, Nursing degree

Principal Investigator

National Cancer Institute, IRCCS Fondazione G. Pascale

About National Cancer Institute, Naples

The National Cancer Institute (NCI) in Naples is a leading research institution dedicated to advancing the understanding and treatment of cancer through innovative clinical trials. As a prominent sponsor of cancer research, the NCI focuses on developing novel therapies, improving patient outcomes, and exploring cutting-edge methodologies in oncology. With a commitment to scientific rigor and collaboration, the NCI in Naples engages in partnerships with academic institutions and healthcare providers to facilitate groundbreaking studies that address critical challenges in cancer care. Their mission is to translate research findings into effective treatments, ultimately enhancing the lives of patients affected by cancer.

Locations

Naples, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported